Covered recipient · General Payments record
CAMILA NAHIR FONTANE
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2025
$506.59
- Reported across 17 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.59 | 16 |
| Education | $72.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.88 | 10 |
| GENZYME CORPORATION | $168.00 | 4 |
| SANOFI-AVENTIS U.S. LLC | $72.00 | 1 |
| Janssen Pharmaceuticals, Inc | $42.71 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $506.59 | 17 |
Payment records · PY2025 (17)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.08 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868444 | CMS |
| ABBVIE INC. | $23.87 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868446 | CMS |
| ABBVIE INC. | $10.85 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868448 | CMS |
| ABBVIE INC. | $24.08 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868450 | CMS |
| ABBVIE INC. | $23.54 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868452 | CMS |
| ABBVIE INC. | $23.70 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868454 | CMS |
| ABBVIE INC. | $23.66 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868456 | CMS |
| ABBVIE INC. | $23.83 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868458 | CMS |
| ABBVIE INC. | $23.66 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868460 | CMS |
| ABBVIE INC. | $22.61 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201868462 | CMS |
| GENZYME CORPORATION | $39.23 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233705186 | CMS |
| GENZYME CORPORATION | $43.44 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233705180 | CMS |
| GENZYME CORPORATION | $42.68 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233705206 | CMS |
| GENZYME CORPORATION | $42.65 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233705198 | CMS |
| Janssen Pharmaceuticals, Inc | $19.26 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174861588 | CMS |
| Janssen Pharmaceuticals, Inc | $23.45 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174866645 | CMS |
| SANOFI-AVENTIS U.S. LLC | $72.00 | 08/28/2025 | Education | Undisputed | 06/30/2026 | 1233705164 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.